NCT04389567View on ClinicalTrials.gov

Famotidine Outpatient COVID-19 Treatment Study

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

May 12, 2020

Primary Completion Date

May 25, 2020

Study Completion Date

May 25, 2020

Conditions
COVID-19
Interventions
DRUG

Famotidine

Use of oral Famotidine.

Trial Locations (1)

11724

Cold Spring Harbor Laboratory, Cold Spring Harbor

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
collaborator

Cold Spring Harbor Laboratory

OTHER

lead

Northwell Health

OTHER

NCT04389567 - Famotidine Outpatient COVID-19 Treatment Study | Biotech Hunter | Biotech Hunter